Cited by 256Cannabis and Cannabinoid ResearchRadiopharmaceutical Chemistry and ApplicationsNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 12 of the 15 references it cites were found in a registry or an index.

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors

Gatley, S.John, Gifford, Andrew N., Volkow, Nora D., Lan, Ruoxi, Makriyannis, Alexandros·1996·European Journal of Pharmacology

DOI 10.1016/0014-2999(96)00279-8

Open this paper in CoChat — free account

Abstract

We have investigated the binding of 123I-labeled N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methy l-1 H-pyrazole-3-carboxamide (AM251), an analog of the cannabinoid receptor antagonist SR141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-me thyl-1 H-pyrazole-3-carboxamide] in the mouse brain. Following intravenous injection, the peak whole-brain uptake of about 1% of the administered activity occurred at about 2 h. By 8 h radioactivity in brain had declined to about half its peak value. High-performance liquid chromatographic analysis showed that > 70% of radioactivity extracted from brain at 2 h was still present as [123I]AM251. Co-injection of SR141716A inhibited the in vivo brain binding of [123I]AM251 dose dependently. At 2 mg/kg, the highest dose that could be tested, inhibition was 50% at 2 h post-administration. The ED50 value calculated assuming that 2 mg/kg gave near-maximal inhibition was about 0.1 mg/kg. In contrast to the brain, radioactivity in other major organs (blood, liver, kidney, heart and lung) was little affected by SR141716A. The regional binding of [123I]AM251 in the brain was consistent with the published distribution of cannabinoid receptors in rat brain, in that the order was hippocampus, striatum > cerebellum > brain stem. delta 9-Tetrahydrocannabinol co-administered intravenously at 10 mg/kg, a dose which induced catalepsy and decreased locomotor activity, decreased the 2 h brain uptake of [123I]AM251 by 10%, but this was not significant (P = 0.08). In in vitro binding assays with mouse hippocampal membranes, tetrahydrocannabinol inhibited binding of [123I]AM251 with an IC50 value of about 700 nM, compared with about 0.2 nM for SR141716A.

Integrity signals

Registry

Crossref · 10.1016/0014-2999(96)00279-8

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Health aspects of cannabis
Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500
SPECT imaging of striatal dopamine release after amphetamine challenge.
Laruelle, M. A., Abi‐Dargham, A., van Dyck, C. H., Rosenblatt, W., Zea‐Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., Hoffer, P. B., & Kung, H. F. (1995) · PubMed · Cited by 333
Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.
Compton, D. M., Gold, L. H., Ward, S. J., Balster, R. L., & Martin, B. R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10448-5 · Cited by 288
Graphical, Kinetic, and Equilibrium Analyses of in vivo [ 123 I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects
Laruelle, M. A., Wallace, E. A., Seibyl, J. P., Baldwin, R. M., Zea‐Ponce, Y., Zoghbi, S. S., Neumeyer, J. L., Charney, D. S., Hoffer, P. B., & Innis, R. B. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.131 · Cited by 268

Show all 15 references

Research works printed but not linked: 4

Chait, 1992, Effects of smoked marijuana on human performance: a critical review, 387
Johnston, 1995, National Survey Results on Drug Use from the Monitoring the Future Study, 1975–1994, Vol. 1
Lichtmann, 1995, The novel cannabinoid antagonist SR141716A blocks delta-9 THC impairment of working memory in rats, Soc. Neurosci. Abstr., 21, 167
Marciniak, 1991, Fluorine-18 labeled tetrahydrocannabinol: synthesis and PET studies in a baboon, J. Label. Compd., 30, 413

Sorted by citations

Items 101–200 of 256

Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: behavioral, electrophysiological and neurochemical evidence
Barbieri, M., Ossato, A., Canazza, I., Trapella, C., Borelli, A. C., Beggiato, S., Rimondo, C., Serpelloni, G., Ferraro, L., & Marti, M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.027 · Cited by 56
Consensus guidelines for the perioperative management of patients undergoing endoscopic retrograde cholangiopancreatography
Azimaraghi, O., Bilal, M., Amornyotin, S., Arain, M. A., Behrends, M., Berzin, T. M., Buxbaum, J. L., Choice, C., Fassbender, P. J., Sawhney, M., et al. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.03.012 · Cited by 58
Targeting the endocannabinoid system in treating brain disorders
Bahr, B. A., Karanian, D. A., Makanji, S. S., & Makriyannis, A. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.4.351 · Cited by 57
Self-citation
[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Δ9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients
Berding, G., Müller-Vahl, K., Schneider, U., Gielow, P., Fitschen, J., Stuhrmann, M., Harke, H., Buchert, R., Donnerstag, F., Hofmann, M., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.005 · Cited by 54
Vascular effects of Δ9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta
O’Sullivan, S. E., Kendall, D. A., & Randall, M. D. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.11.056 · Cited by 53
Pharmacological Characterization of a Novel Cannabinoid Ligand, MDA19, for Treatment of Neuropathic Pain
Xu, J. J., Diaz, P., Astruc‐Diaz, F., Craig, S. L., Muñoz, E., & Naguib, M. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181e0cdaf · Cited by 51
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors
Desroches, J., Charron, S., Bouchard, J., & Beaulieu, P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.006 · Cited by 51
The Cav3–Kv4 Complex Acts as a Calcium Sensor to Maintain Inhibitory Charge Transfer during Extracellular Calcium Fluctuations
Anderson, D., Engbers, J. D. T., Heath, N. C., Bartoletti, T. M., Mehaffey, W. H., Zamponi, G. W., & Turner, R. W. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5384-12.2013 · Cited by 51
The effects of Δ9‐tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide
O’Sullivan, S. E., Kendall, D. A., & Randall, M. D. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706218 · Cited by 50
The Cannabinoid 1 Receptor Antagonist, AM251, Prolongs the Survival of Rats with Severe Acute Pancreatitis
Matsuda, K., Mikami, Y., Takeda, K., Fukuyama, S., Egawa, S., Sunamura, M., Maruyama, I., & Matsuno, S. (2005) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.207.99 · Cited by 50
Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats
Mathes, C. M., Ferrara, M., & Rowland, N. E. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00150.2008 · Cited by 50
TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation
Hofmann, N., Barth, S., Waldeck‐Weiermair, M., Klec, C., Strunk, D., Malli, R., & Graier, W. F. (2014) · Biology Open · doi:10.1242/bio.20149571 · Cited by 49
Development of Radioligands for In Vivo Imaging of Type 1 Cannabinoid Receptors (CB1) in Human Brain
Horti, A. G., & Laere, K. V. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549380 · Cited by 49
Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox
Dao, M., & François, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.720734 · Cited by 49
Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons
Patil, M. J., Patwardhan, A. M., Salas, M. M., Hargreaves, K., & Akopian, A. N. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.024 · Cited by 44
Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine
Greco, R., Demartini, C., Zanaboni, A., Casini, I., Icco, R. D., Reggiani, A. M., Misto, A., Piomelli, D., & Tassorelli, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105157 · Cited by 44
R(+)-Methanandamide Induces Cyclooxygenase-2 Expression in Human Neuroglioma Cells via a Non-cannabinoid Receptor-Mediated Mechanism
Ramer, R., Brune, K., Pahl, A. M., & Hinz, B. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5518 · Cited by 44
Synthesis and Structure−Activity Relationship of a Novel Series of Aminoalkylindoles with Potential for Imaging the Neuronal Cannabinoid Receptor by Positron Emission Tomography
Willis, P. G., Pavlova, O. A., Chefer, S. I., Vaupel, D. B., Mukhin, A. G., & Horti, A. G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0502743 · Cited by 43
Mechanism-based medication development for the treatment of nicotine dependence
Xi, Z., Spiller, K. J., & Gardner, E. L. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.46 · Cited by 42
Synthesis and structure–activity relationships (SARs) of 1,5-diarylpyrazole cannabinoid type-1 (CB1) receptor ligands for potential use in molecular imaging
Donohue, S. R., Halldin, C., & Pike, V. W. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.01.047 · Cited by 42
AM251, cannabinoids receptors ligand, improves recognition memory in rats
Bialuk, I., & Winnicka, M. M. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70578-3 · Cited by 43
Rational Design, Synthesis, and Pharmacological Properties of New 1,8-Naphthyridin-2(1H)-on-3-Carboxamide Derivatives as Highly Selective Cannabinoid-2 Receptor Agonists
Manera, C., Saccomanni, G., Adinolfi, B., Benetti, V., Ligresti, A., Cascio, M. G., Tuccinardi, T., Lucchesi, V., Martinelli, A., Nieri, P., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801563d · Cited by 41
Additive subthreshold dose effects of cannabinoid CB1 receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests
Takahashi, E., Katayama, M., Niimi, K., & Itakura, C. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.020 · Cited by 41
Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury
Hama, A., & Sagen, J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.09.002 · Cited by 40
The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats
Hodge, J., Bow, J. P., Plyler, K. S., Vemuri, K. V., Wisniecki, A., Salamone, J. D., Makriyannis, A., & McLaughlin, P. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.010 · Cited by 40
Self-citation
Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387
McLaughlin, P. J., Liu, Q., Wood, J. T., Wisniecki, A., Winston, K. M., Swezey, L. A., Ishiwari, K., Betz, A. J., Pandarinathan, L., Xu, W., et al. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.02.022 · Cited by 40
Self-citation
The Antinociceptive Effects of Local Injections of Propofol in Rats Are Mediated in Part by Cannabinoid CB1 and CB2 Receptors
Guindon, J., LoVerme, J., Piomelli, D., & Beaulieu, P. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000263278.05423.a3 · Cited by 38
Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system
Fernández‐Solari, J., Scorticati, C., Mohn, C. E., Laurentiis, A. D., Billi, S. C., Franchi, A. M., McCann, S. M., & Rettori, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307346101 · Cited by 38
CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice
Kruk-Słomka, M., & Biała, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.023 · Cited by 37
Involvement of opioid system in antidepressant‐like effect of the cannabinoid CB 1 receptor inverse agonist AM ‐251 after physical stress in mice
Ostadhadi, S., Haj‐Mirzaian, A., Nikoui, V., Kordjazy, N., & Dehpour, A. R. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12518 · Cited by 36
Cannabis sativaand the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation
Farrimond, J. A., Mercier, M. S., Whalley, B. J., & Williams, C. M. (2011) · Phytotherapy Research · doi:10.1002/ptr.3375 · Cited by 37
Behavioral effects of the novel cannabinoid full agonist AM 411
McLaughlin, P. J., Lü, D., Winston, K. M., THAKUR, G., Swezey, L. A., Makriyannis, A., & Salamone, J. D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.02.005 · Cited by 36
Self-citation
Blocking the Cannabinoid Receptors: Drug Candidates and Therapeutic Promises
Muccioli, G. G. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790153 · Cited by 36
Cannabinoid Modulation of Cutaneous Aδ Nociceptors During Inflammation
Potenzieri, C., Brink, T. S., Pacharinsak, C., & Simone, D. A. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90809.2008 · Cited by 35
In vivo imaging of the brain cannabinoid receptor
Gifford, A. N., Makriyannis, A., Volkow, N. D., & Gatley, S. J. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00148-2 · Cited by 34
Self-citation
Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats
Tallett, A. J., Blundell, J. E., & Rodgers, R. J. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.08.007 · Cited by 33
Fetal Cerebral Circulation as Target of Maternal Alcohol Consumption
Bukiya, A. N., & Dopico, A. M. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13755 · Cited by 35
Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors
Kargar, H. M.-P., Azizi, H., Mirnajafi‐Zadeh, J., Mani, A. R., & Semnanian, S. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.050 · Cited by 32
Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice
Toscano, C. D., Ueda, Y., Tomita, Y. A., Vicini, S., & Bosetti, F. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.10.004 · Cited by 33
PET Imaging Studies in Drug Abuse
Fowler, J. S., & Volkow, N. D. (1998) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659809028936 · Cited by 32
Self-citation
Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation
Tallett, A. J., Blundell, J. E., & Rodgers, J. R. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282eff0a9 · Cited by 32
HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test
Gühring, H., Schuster, J., Hamza, M., Ateş, M., Kotalla, C., & Brune, K. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01313-9 · Cited by 31
2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling
Su, J. Y., & Vo, A. C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.016 · Cited by 31
The molecular basis of the cooperation between EGF, FGF and eCB receptors in the regulation of neural stem cell function
Suetterlin, P., Williams, E. J., Chambers, D. J., Saraf, K. A., von Schack, D., Reisenberg, M., Doherty, P., & Williams, G. H. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.006 · Cited by 30
Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors
Zádor, F., & Wollemann, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.015 · Cited by 30
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor
Wyatt, R. M., Fraser, I. C., Welty, N., Lord, B., Wennerholm, M. L., Sutton, S. W., Ameriks, M. K., Dugovic, C., Yun, S., White, A., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.262139 · Cited by 30
Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies
Idris, A. I. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246173 · Cited by 29
Δ9‐Tetrahydrocannabinol regulates the p53 post‐translational modifiers Murine double minute 2 and the Small Ubiquitin MOdifier protein in the rat brain
Gowran, A., Murphy, C. E., & Campbell, V. A. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.09.056 · Cited by 29
Influence of the CB1 receptor antagonist, AM 251, on the regional haemodynamic effects of WIN‐55212‐2 or HU 210 in conscious rats
Gardiner, S. M., March, J. E., Kemp, P. A., & Bennett, T. M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704750 · Cited by 29
Flurbiprofen inhibits capsaicin induced calcitonin gene related peptide release from rat spinal cord via an endocannabinoid dependent mechanism
Seidel, K., Hamza, M., Ateş, M., & Gühring, H. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01366-6 · Cited by 28
Diuretic effects of cannabinoid agonists in mice
Chopda, G. R., Vemuri, K. V., Sharma, R., Thakur, G. A., Makriyannis, A., & Paronis, C. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.053 · Cited by 27
Self-citation
Endocannabinoids Part I: Molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors
Marzo, O. V. D., PETROCELLIS, L. D., & Bisogno, T. (2001) · Emerging Therapeutic Targets · doi:10.1517/14728222.5.2.241 · Cited by 27
Chronic administration of AM251 improves albuminuria and renal tubular structure in obese rats
Jenkin, K. A., O’Keefe, L., Simcocks, A. C., Grinfeld, E., Mathai, M. L., McAinch, A. J., & Hryciw, D. H. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0004 · Cited by 27
Acyl‐based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations
de Lago, E., Gustafsson, S. B., Fernández‐Ruíz, J., Nilsson, J. A., Jacobsson, S. O. P., & Fowler, C. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04104.x · Cited by 28
Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats
Sink, K. S., Segovia, K. N., Nunes, E. J., Collins, L. E., Vemuri, K. V., Thakur, G. A., Makriyannis, A., & Salamone, J. D. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1602-8 · Cited by 28
Self-citation
Role of Endocannabinoids and Cannabinoid-1 Receptors in Cerebrocortical Blood Flow Regulation
Iring, A., Ruisanchez, É., Leszl-Ishiguro, M., Horváth, B., Benkő, R., Lacza, Z., Járai, Z., Sándor, P., Marzo, V. D., Pacher, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053390 · Cited by 26
Role of the Endocannabinoid System in Ethanol-Induced Inhibition of Salivary Secretion
Prestifilippo, J. P., Fernández‐Solari, J., Medina, V. A., Rettori, V., & Elverdin, J. C. (2009) · Alcohol and Alcoholism · doi:10.1093/alcalc/agp040 · Cited by 26
The in Vitro and in Vivo Cardiovascular Effects of Δ9-Tetrahydrocannabinol in Rats Made Hypertensive by Chronic Inhibition of Nitric-Oxide Synthase
O’Sullivan, S. E., Randall, M. D., & Gardiner, S. M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116566 · Cited by 26
Developmental Decrease in Short-Term Facilitation at Schaffer Collateral Synapses in Hippocampus Is mGluR1 Sensitive
Speed, H. E., & Dobrunz, L. E. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00625.2007 · Cited by 26
AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells
Yoshinaga, T., Uwabe, K., Naito, S., Higashino, K., Nakano, T., Numata, Y., & Kihara, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167848 · Cited by 25
Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion
Veiga, M. A. L., Bloise, F. F., Costa-e-Sousa, R. H., Souza, L. L., Almeida, N. A. D. S., Oliveira, K. J., & Pazos-Moura, C. C. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0380 · Cited by 24
IP3R-mediated Ca2+ release is modulated by anandamide in isolated cardiac nuclei
Currie, S., Rainbow, R. D., Ewart, M., Kitson, S. M., Herradón, E., Kane, K. A., & McCarron, J. G. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.07.005 · Cited by 24
Developmental Changes in Retrograde Messengers Involved in Depolarization-Induced Suppression of Excitation at Parallel Fiber-Purkinje Cell Synapses in Rodents
Crépel, F. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00735.2006 · Cited by 24
Cannabinoids, Chemical Senses, and Regulation of Feeding Behavior
Tarragón, E., & Moreno, J. J. (2018) · Chemical Senses · doi:10.1093/chemse/bjy068 · Cited by 23
Δ9-Tetrahydrocannabinol reverses TNFα-induced increase in airway epithelial cell permeability through CB2 receptors
Shang, V., Kendall, D. A., & Roberts, R. E. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.008 · Cited by 23
Candidate PET radioligands for cannabinoid CB1 receptors: [18F]AM5144 and related pyrazole compounds
Li, Z., Gifford, A. J., Liu, Q., Thotapally, R., Ding, Y., Makriyannis, A., & Gatley, S. J. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.02.007 · Cited by 23
Self-citation
A Cannabinoid Ligand, Anandamide, Exacerbates Endotoxin-Induced Uveitis in Rabbits
Altinsoy, A., Dileköz, E., Kul, O., İlhan, S. Ö., Tunçcan, Ö. G., Seven, I., Bağrıaçık, E. Ü., Sarıoğlu, Y., Or, M., & Ercan, Z. S. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0049 · Cited by 22
Oxyhomologation of the Amide Bond Potentiates Neuroprotective Effects of the Endolipid N-Palmitoylethanolamine
Lombardi, G., Miglio, G., Varsaldi, F., Minassi, A., & Appendino, G. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112987 · Cited by 23
Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion
Fernández‐Solari, J., Prestifilippo, J. P., Ossola, C. A., Rettori, V., & Elverdin, J. C. (2010) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2010.05.006 · Cited by 21
Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat
Vera, G., López-Pérez, A. E., Uranga, J. A., Girón, R., Martín‐Fontelles, M. I., & Abalo, R. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00037 · Cited by 21
Test–retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [11C]MePPEP
Barros, D. A. R., McGinnity, C. J., Rosso, L., Heckemann, R. A., Howes, O. D., Brooks, D. J., Duncan, J. S., Turkheimer, F., Koepp, M. J., & Hammers, A. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.04.020 · Cited by 21
Involvement of CB1-receptors and β-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats
Gardiner, S. M., March, J. E., Kemp, P. A., & Bennett, T. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00851.2004 · Cited by 21
Are CB1 receptor antagonists nootropic or cognitive impairing agents?
Varvel, S. A., Wise, L. E., & Lichtman, A. H. (2009) · Drug Development Research · doi:10.1002/ddr.20334 · Cited by 20
Genome-wide Expression Profiling Revealed Peripheral Effects of Cannabinoid Receptor 1 Inverse Agonists in Improving Insulin Sensitivity and Metabolic Parameters
Zhao, W., Fong, O., Muise, E. S., Thompson, J. R., Weingarth, D. T., Qian, S., & Fong, T. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064980 · Cited by 20
Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716)
van Diepen, H. C., Schlicker, E., & Michel, M. C. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0327-2 · Cited by 20
In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans
Laere, K. V. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0505-3 · Cited by 20
New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance
Lipina, C., Rastedt, W., Irving, A. J., & Hundal, H. S. (2012) · BioEssays · doi:10.1002/bies.201200031 · Cited by 19
CB 1 receptor signalling mediates cannabidiol-induced panicolytic-like effects and defensive antinociception impairment in mice threatened by Bothrops jararaca lancehead pit vipers
Rodrigues, B. M. D. P., & Coimbra, N. C. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221115755 · Cited by 18
Chapter 11 Glucocorticoid‐Regulated Crosstalk Between Arachidonic Acid and Endocannabinoid Biochemical Pathways Coordinates Cognitive‐, Neuroimmune‐, and Energy Homeostasis‐Related Adaptations to Stress
Malcher‐Lopes, R., & Buzzi, M. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81011-x · Cited by 19
Anandamide injected into the lateral ventricle of the brain inhibits submandibular salivary secretion by attenuating parasympathetic neurotransmission
Fernández‐Solari, J., Prestifilippo, J. P., Vissio, P. G., Ehrhart‐Bornstein, M., Bornstein, S. R., Rettori, V., & Elverdin, J. C. (2009) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2009000600010 · Cited by 18
Behavioural and pharmacological characterization of a novel cannabinomimetic adamantane-derived indole, APICA, and considerations on the possible misuse as a psychotropic spice abuse, in C57bl/6J MICE
Cannizzaro, C., Malta, G., Argo, A., Brancato, A., Roda, G., Casagni, E., Fumagalli, L., Valoti, E., Froldi, R., Procaccianti, P., et al. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2015.12.035 · Cited by 17
Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists
Pandey, P., Roy, K. K., Liu, H., Ma, G., Pettaway, S., Alsharif, W. F., Gadepalli, R. S., Rimoldi, J. M., McCurdy, C. R., Cutler, S. J., et al. (2018) · Molecules · doi:10.3390/molecules23102630 · Cited by 17
α-Tocopherol and α-tocopheryl phosphate interact with the cannabinoid system in the rodent hippocampus
Crouzin, N., Ferreira, M. D. J., Cohen‐Solal, C., M’Kadmi, C., Bernad, N., Martínez, J., Barbanel, G., Vignes, M., & Guiramand, J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.07.012 · Cited by 17
Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054
McLaughlin, P. J., Thakur, G. A., Vemuri, K. V., McClure, E. D., Brown, C., Winston, K. M., Wood, J. T., Makriyannis, A., & Salamone, J. D. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.04.011 · Cited by 17
Self-citation
Impacts of cannabinoid receptor ligands on nicotine- and chronic mild stress-induced cognitive and depression-like effects in mice
Pękała, K., Michalak, A., Kruk-Słomka, M., Budzyńska, B., & Biała, G. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.03.019 · Cited by 16
Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens
Kucera, R., Bouskila, J., Elkrief, L., Fink‐Jensen, A., Palmour, R. M., Bouchard, J., & Ptito, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-26826-2 · Cited by 16
Chapter 7 Cannabinoid Receptor CB1 Antagonists
Bifulco, M., Santoro, A., Laezza, C., & Malfitano, A. M. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81007-8 · Cited by 16
CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX ‐2 Activity and Oxidative Stress
Martínez‐Torres, A. M., & Morán, J. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70099 · Cited by 15
Developmental Changes in Agonist-Induced Retrograde Signaling at Parallel Fiber–Purkinje Cell Synapses: Role of Calcium-Induced Calcium Release
Crépel, F., & Daniel, H. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00376.2007 · Cited by 15
Endocannabinoids mediate hyposalivation induced by inflammogens in the submandibular glands and hypothalamus
Prestifilippo, J. P., Medina, V. A., Mohn, C. E., Rodríguez, P., Elverdin, J. C., & Fernández‐Solari, J. (2013) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2013.04.003 · Cited by 15
Gestational Age-Dependent Interplay between Endocannabinoid Receptors and Alcohol in Fetal Cerebral Arteries
Simakova, M. N., Tobiasz, A., Sullivan, R. D., Bisen, S., Duncan, J. R., Sullivan, J. P., Davison, S., Tate, D. L., Barnett, S., Mari, G. C., et al. (2018) · Journal of Drug and Alcohol Research · doi:10.4303/jdar/236068 · Cited by 14
CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning
Pedroza-Llinás, R., Méndez‐Díaz, M., Ruiz‐Contreras, A. E., & Prospero-Garcia, O. E. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.09.032 · Cited by 14
A Method for Parallel Solid-Phase Synthesis of Iodinated Analogues of the CB1Receptor Inverse Agonist Rimonabant
Spivey, A. C., Tseng, C., Jones, T. C., Kohler, A. D., & Ellames, G. J. (2009) · Organic Letters · doi:10.1021/ol902038y · Cited by 14
Endocannabinoid CB1 receptor-mediated rises in Ca2+ and depolarization-induced suppression of inhibition within the laterodorsal tegmental nucleus
Soni, N., & Kohlmeier, K. A. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0969-4 · Cited by 14
Lack of a Significant Effect of Cannabinoids upon the Uptake of 2-Deoxy-D-Glucose by Caco-2 Cells
Gonçalves, P., Araújo, J. R., Azevedo, I., & Martel, F. (2008) · Pharmacology · doi:10.1159/000127408 · Cited by 14
Radiosynthesis and Biodistribution in Mice of a 18F-Labeled Analog of O-1302 for Use in Cerebral CB1 Cannabinoid Receptor Imaging
Nojiri, Y., Ishiwata, K., Qinggeletu, Tobiishi, S., Sasada, T., Yamamoto, F., Mukai, T., & Maëda, M. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1274 · Cited by 13
Neurophysiological evidence for the presence of cannabinoid CB1 receptors in the laterodorsal tegmental nucleus
Soni, N., Satpathy, S., & Kohlmeier, K. A. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12730 · Cited by 12
Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior
Wong, M. Y., Borgkvist, A., Choi, S. J., Mosharov, E. V., Bamford, N. S., & Sulzer, D. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.022 · Cited by 12
Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the NematodeCaenorhabditis elegans
Rodrigues, P. R., Kaul, T. K., Ho, J., Lucanic, M., Burkewitz, K., Mair, W. B., Held, J. M., Bohn, L., & Gill, M. S. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.026997 · Cited by 11
Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol
Qiao, Z., Kumar, A., Kumar, P., & Song, Z.-H. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.05.001 · Cited by 11

Authors: Gatley, S. J., Gifford, A. N., Volkow, N. D., Lan, R., & Makriyannis, A.
Affiliations: Brookhaven National Laboratory (US)
University of Connecticut (US)
Corresponding author: Gatley, S.John
ORCID: Volkow, Nora D.
Makriyannis, Alexandros
Venue: European Journal of Pharmacology
Publisher: Elsevier BV
Published: 1996-07
Volume: 307
Issue: 3
Pages: 331-338
ISSN: 0014-2999 (ISSN-L)
DOI: 10.1016/0014-2999(96)00279-8
OpenAlex: W1979829009
Cited by: 252
References: 15
Citations by year: 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 7 · 2017: 1 · 2016: 8 · 2015: 12 · 2014: 8 · 2013: 13 · 2012: 11
FWCI: 1.49
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: European Journal of Pharmacology (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Energy
Sanofi
National Institute on Drug Abuse (DA-06278, R01DA006278, DA07515, DA-03801)
Brookhaven National Laboratory
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: CB1 receptor, radioiodination, SR141716A, radioligand binding, brain receptor distribution, tetrahydrocannabinol, delta-9-tetrahydrocannabinol, hippocampus, striatum, cerebellum, brainstem
MeSH terms: Rimonabant, Animals, Brain, Cell Membrane, Chromatography, High Pressure Liquid, Hippocampus, Iodine Radioisotopes, Isotope Labeling, Male, Mice, Inbred Strains, Motor Activity, Piperidines, Protein Binding, Pyrazoles, Radioligand Assay, Receptors, Drug, Dronabinol, Tissue Distribution, Receptors, Cannabinoid, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks